Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis

Publisher： Karger

E-ISSN： 1664-5553|5|3|175-189

ISSN： 2235-1795

Source： Liver Cancer, Vol.5, Iss.3, 2016-05, pp. : 175-189

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sorafenib Therapy in Patients with Advanced Hepatocellular Carcinoma in Advanced Liver Cirrhosis

By  

Digestion, Vol. 83, Iss. 4, 2011-02 ,pp. : 275-282

Karger

Access to resources Recommend Favorite

Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: Is there a lead-time bias?

By Huo Teh-Ia   Huang Yi-Hsiang   Chiang Jen-Huei   Wu Jaw-Ching   Lee Pui-Ching   Chi Chin-Wen   Lee Shou-Dong  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 4, 2007-01 ,pp. : 485-492

Informa Healthcare

Access to resources Recommend Favorite

Hepatocellular Carcinoma in Child-Pugh C Cirrhosis: Prognostic Factors and Survival Benefit of Nontransplant Treatments

By  

Digestive Diseases, Vol. 31, Iss. 5-6, 2013-11 ,pp. : 490-498

Karger

Access to resources Recommend Favorite

Locoregional Therapy for Hepatocellular Carcinoma

By  

Liver Cancer, Vol. 4, Iss. 3, 2015-06 ,pp. : 163-164

Karger

Access to resources Recommend Favorite

Accelerated progression of hepatocellular carcinoma with cytokeratin 19 expression during treatment with lamivudine for hepatitis B virus-related liver cirrhosis

By Yamada Masayoshi   Shiroeda Hisakazu   Sato Katsuaki   Hayashi Ranji   Nomura Tomoe   Tsutsumi Mikihiro   Arisawa Tomiyasu  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 2, 2011-02 ,pp. : 249-251

Informa Healthcare

Access to resources Recommend Favorite